Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

LY-3305677 is safe and shows body weight-lowering effect in FIH trial

July 8, 2021

Dual GIP/GLP-1 receptor agonist HISHS-2001 displays efficacy in type 2 diabetes model

July 8, 2021

NMPA accepts IND application for TST-002 anti-sclerostin monoclonal antibody

July 7, 2021

SYNB-1934, optimized live bacterial therapeutic for the treatment of phenylketonuria

July 6, 2021

Dose-dependent weight loss seen in first-in-human study of LY-3437943

July 6, 2021

GNT-0003 restores UGT1A1 expression in patients with Crigler-Najjar syndrome

July 5, 2021

Beijing Tuojie Biopharmaceutical patents CaSR agonists

July 5, 2021

Intestinal MYC modulates weight-related metabolic dysfunction

July 5, 2021

Sichuan Haisco Pharmaceutical identifies new ENPP2 inhibitors

July 5, 2021

Ildong announces initiation of phase I study of IDG-16177 in Germany

July 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.